Vital Farms, Inc. (VITL) shares plummeted 5.11% in the pre-market session on Thursday, despite reporting better-than-expected fourth-quarter earnings. The company's stock took a hit as investors reacted to the ongoing supply constraints caused by the impact of HPAI (Highly Pathogenic Avian Influenza) on poultry flocks across the United States.
The Austin-based company reported a 22.2% increase in net revenue to $166 million for the fourth quarter ended December 29, 2024, driven by volume growth and price/mix benefits. However, the company acknowledged that it had experienced supply constraints at the start of 2025 due to the impact of HPAI on poultry flocks in the U.S.
Despite the challenges, Vital Farms maintained an optimistic outlook for 2025. The company expects its supply chain investments in 2024 and 2025 to bear fruit in the second half of the year, helping drive its net revenue and adjusted EBITDA guidance for 2025. Vital Farms projected net revenue of at least $740 million and adjusted EBITDA of at least $100 million for the full year 2025, representing growth of at least 22% and 15%, respectively, compared to fiscal year 2024.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。